Showing 20 of 80 recruiting trials for “idiopathic-pleuroparenchymal-fibroelastosis”
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for IPF
👨⚕️ Chadwick Prodromos, MD, The Foundation for Orthopaedics and Regenerative Medicine📍 1 site📅 Started Jul 2022View details ↗
RecruitingNCT05042219 ↗
Effects of Pulmonary Diseases and Their Treatment on Cardiac Function
RecruitingNCT05191381 ↗
Immune Modulation by Exosomes in COVID-19
👨⚕️ Manfred Weiss, MD, Clinic of Anaesthesiology and Intensive Care Medicine📍 1 site📅 Started Dec 2021View details ↗
Telerehabilitation in Patients With Idiopathic Pulmonary Fibrosis
Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole
👨⚕️ Professor Andrew Wilson, Norfolk and Norwich University Hospitals NHS Foundation Trust📍 20 sites📅 Started Jun 2021View details ↗
Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis
RecruitingNCT04442711 ↗
Cohort of IPF Patients Experiencing an Exacerbation
RecruitingNCT04304898 ↗
An International Patient-led Registry in Fibrotic Interstitial Lung Diseases Using eHealth Technology
RecruitingNCT04314323 ↗
National Registry of IRPF in China
RecruitingNCT04312854 ↗
A Prospective Cohort Study of IRPF in China
👨⚕️ Wen Zhang, MD, Department of Rheumatology,Peking Union Medical College Hospital📍 1 site📅 Started Jan 2020View details ↗
Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis
👨⚕️ Hui Gao, Doctor, Peking University International Hospital📍 1 site📅 Started Jul 2018View details ↗
RecruitingNCT03478553 ↗
The Genetics of Pulmonary Fibrosis
RecruitingNCT04160715 ↗
Korean Idiopathic Pulmonary Fibrosis Registry
High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With Nintedanib
RecruitingNCT01915511 ↗
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
👨⚕️ Scott Palmer, MD, Duke Clinical Research Institute, Duke University📍 41 sites📅 Started Jun 2014View details ↗
RecruitingNCT03437486 ↗
Mechanisms of Familial Pulmonary Fibrosis
👨⚕️ Margaret Salisbury, MD, Vanderbilt University Medical Center📍 1 site📅 Started Jan 2009View details ↗
RecruitingNCT00373841 ↗
Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
👨⚕️ Kevin F Gibson, MD, University of Pittsburgh - Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease📍 1 site📅 Started Oct 2005View details ↗
RecruitingNCT00470327 ↗
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
RecruitingNCT00258570 ↗
Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
👨⚕️ Kevin F Gibson, MD, University of Pittsburgh, Simmons Center for ILD📍 1 site📅 Started Jan 2003View details ↗
← PreviousPage 4 of 4
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →